Stryker Says Not in Talks to Buy Boston Scientific

Shares of Stryker Corp. (SYK)  shot up in premarket trading on Wednesday, June 13, after the medical technology firm said in an 8-K filing that it wasn't in talks to acquire Boston Scientific Corp. (BSX) .

Stryker's shares jumped nearly 7% to $173.89. Shares of Boston Scientific fell 6.5% to $31.65.

The filing came on the heels of a Wall Street Journal article on Monday stating that Kalamazoo, Mich.-based Stryker had recently made a takeover approach to Marlborough Mass.-based Boston Scientific.

More from Markets

Dow Dives on Earnings Disappointments From Caterpillar, 3M

Dow Dives on Earnings Disappointments From Caterpillar, 3M

Tesla Critic Citron Research Changes Its Mind, Goes Long on the EV Maker

Tesla Critic Citron Research Changes Its Mind, Goes Long on the EV Maker

Philip Morris Rolls Out New Smokeless Cigs to Fire Up Sales

Philip Morris Rolls Out New Smokeless Cigs to Fire Up Sales

Verizon Beats Q3 Earnings Estimate, Postpaid Phone Additions Top Forecasts

Verizon Beats Q3 Earnings Estimate, Postpaid Phone Additions Top Forecasts

Stocks Tumble, Dow Futures Plunge as Growth Risks Catch Up to Global Markets

Stocks Tumble, Dow Futures Plunge as Growth Risks Catch Up to Global Markets